PMID- 20092643 OWN - NLM STAT- MEDLINE DCOM- 20100322 LR - 20211020 IS - 1471-2350 (Electronic) IS - 1471-2350 (Linking) VI - 11 DP - 2010 Jan 21 TI - Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). PG - 12 LID - 10.1186/1471-2350-11-12 [doi] AB - BACKGROUND: The polycystic ovary syndrome (PCOS), a common endocrine disorder in women of child-bearing age, mainly characterised by chronic anovulation and hyperandrogenism, is often associated with insulin resistance (IR) and obesity. Its etiology and the role of IR and obesity in PCOS are not fully understood. We examined the influence of validated genetic variants conferring susceptibility to obesity and/or type 2 diabetes mellitus (T2DM) on metabolic and PCOS-specific traits in patients with PCOS. METHODS: We conducted an association study in 386 patients with PCOS (defined by the Rotterdam-criteria) using single nucleotide polymorphisms (SNPs) in or in proximity to the fat mass and obesity associated gene (FTO), insulin-induced gene-2 (INSIG2), transcription factor 7-like 2 gene (TCF7L2) and melanocortin 4 receptor gene (MC4R). To compare the effect of FTO obesity risk alleles on BMI in patients with PCOS to unselected females of the same age range we genotyped 1,971 females from the population-based KORA-S4 study (Kooperative Gesundheitsforschung im Raum Augsburg, Survey 4). RESULTS: The FTO risk allele was associated with IR traits and measures of increased body weight. In addition, the TCF7L2 SNP was associated with body weight traits. For the SNPs in the vicinity of INSIG2 and MC4R and for the other examined phenotypes there was no evidence for an association. In PCOS the observed per risk allele effect of FTO intron 1 SNP rs9939609 on BMI was +1.56 kg/m2, whereas it was +0.46 kg/m2 in females of the same age range from the general population as shown previously. CONCLUSION: The stronger effect on body weight of the FTO SNP in PCOS might well have implications for the etiology of the disease. FAU - Tan, Susanne AU - Tan S AD - Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Essen, Germany. FAU - Scherag, Andre AU - Scherag A FAU - Janssen, Onno Eilard AU - Janssen OE FAU - Hahn, Susanne AU - Hahn S FAU - Lahner, Harald AU - Lahner H FAU - Dietz, Tiina AU - Dietz T FAU - Scherag, Susann AU - Scherag S FAU - Grallert, Harald AU - Grallert H FAU - Vogel, Carla Ivane Ganz AU - Vogel CI FAU - Kimmig, Rainer AU - Kimmig R FAU - Illig, Thomas AU - Illig T FAU - Mann, Klaus AU - Mann K FAU - Hebebrand, Johannes AU - Hebebrand J FAU - Hinney, Anke AU - Hinney A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100121 PL - England TA - BMC Med Genet JT - BMC medical genetics JID - 100968552 RN - 0 (DNA Primers) RN - 0 (INSIG2 protein, human) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (MC4R protein, human) RN - 0 (Membrane Proteins) RN - 0 (Proteins) RN - 0 (Receptor, Melanocortin, Type 4) RN - 0 (TCF Transcription Factors) RN - 0 (TCF7L2 protein, human) RN - 0 (Transcription Factor 7-Like 2 Protein) RN - EC 1.14.11.33 (Alpha-Ketoglutarate-Dependent Dioxygenase FTO) RN - EC 1.14.11.33 (FTO protein, human) SB - IM MH - Adult MH - Aged MH - Alpha-Ketoglutarate-Dependent Dioxygenase FTO MH - Base Sequence MH - Body Mass Index MH - DNA Primers/genetics MH - Female MH - Genetic Association Studies MH - *Genetic Variation MH - Genotype MH - Humans MH - Insulin Resistance/genetics MH - Intracellular Signaling Peptides and Proteins/genetics MH - Introns MH - Membrane Proteins/genetics MH - Middle Aged MH - Obesity/genetics/pathology/physiopathology MH - Polycystic Ovary Syndrome/*genetics/pathology/physiopathology MH - Polymorphism, Single Nucleotide MH - Proteins/*genetics MH - Receptor, Melanocortin, Type 4/genetics MH - TCF Transcription Factors/genetics MH - Transcription Factor 7-Like 2 Protein PMC - PMC2824654 EDAT- 2010/01/23 06:00 MHDA- 2010/03/23 06:00 PMCR- 2010/01/21 CRDT- 2010/01/23 06:00 PHST- 2009/06/08 00:00 [received] PHST- 2010/01/21 00:00 [accepted] PHST- 2010/01/23 06:00 [entrez] PHST- 2010/01/23 06:00 [pubmed] PHST- 2010/03/23 06:00 [medline] PHST- 2010/01/21 00:00 [pmc-release] AID - 1471-2350-11-12 [pii] AID - 10.1186/1471-2350-11-12 [doi] PST - epublish SO - BMC Med Genet. 2010 Jan 21;11:12. doi: 10.1186/1471-2350-11-12.